In general, the risk of hypoglycemia decreased over time, and these GLP-1RAs resulted in a hypoglycemia rate of 62.50100.00% at 2 months after treatment in the real-world analysis
It works by mimicking a hormone called GLP-1, which stimulates insulin production and reduces glucose in the bloodstream
If those intentions translate into behavior, as many as four in ten adults could eventually be on a GLP-1 medication
That is an argument for tracking your own experience what, when, how severe, and at what point in treatment and bringing that record to your prescriber, rather than trying to match yourself against a table
Insurers declined to commit to a permanent follow-on model, and the Bridge extension did not resolve that underlying disagreement
No pharmacological overlap washout is needed because both drugs are GLP-1 agonists, though re-escalating through the full semaglutide dose ladder is recommended to minimize GI side effects